CDKN2A and lung adenocarcinoma: To our knowledge, CDKN2A EX2, CDX2, HOXA1 and OPCML constitute the strongest lung adenocarcinoma DNA methylation markers identified to date, and we are working on further evaluations of their potential with great anticipation.